Keyphrases
Israel
100%
Acute Hospital
53%
Israeli
48%
Post-acute Care
41%
Healthcare Workers
35%
Klebsiella Pneumoniae Carbapenemase
34%
Carbapenem-resistant Acinetobacter Baumannii
33%
Carbapenem-resistant Enterobacteriaceae
33%
Methicillin-resistant S. Aureus
32%
Klebsiella Pneumoniae (K. pneumoniae)
26%
Vancomycin-intermediate Staphylococcus Aureus
25%
Hospitalized Patients
24%
Bloodstream Infection
22%
Preventive Measures
21%
Long-term Care Facilities
20%
Tertiary Care Hospital
20%
Central Line-associated Bloodstream Infection (CLABSI)
19%
Antimicrobial Use
19%
Intensive Care Unit
18%
COVID-19
18%
Methicillin-resistant Staphylococcus Aureus
18%
Odds Ratio
17%
Staphylococcus Aureus Bacteremia
17%
KPC-2
17%
National Survey
17%
Prevention Practices
16%
Carbapenemase Genes
16%
Rapid Detection
16%
HVISA
16%
West Nile Fever
16%
Hospital-acquired Urinary Tract Infection
16%
Streptococcus Pneumoniae
16%
National Policy
16%
Community-acquired Bloodstream Infection
16%
Carbapenemase-producing Enterobacterales
16%
Clostridium Difficile Infection
15%
Carbapenem Resistance
13%
Infection Control
13%
Contact Precautions
13%
Infection Prevention
12%
Catheter-associated Urinary Tract Infection (CAUTI)
12%
Post-acute Care Facilities
12%
Active Surveillance
12%
Bacteremia
12%
Infection Rate
10%
Ministry of Health
10%
Antimicrobial
10%
Quantitative PCR
10%
Hospital-acquired
10%
Epidemiology
10%
Medicine and Dentistry
Bloodstream Infection
34%
Carbapenem
33%
Subacute Care
27%
Antiinfective Agent
26%
Intensive Care Unit
25%
Klebsiella pneumoniae
25%
Infection
23%
Health Care
18%
Catheter Infection
18%
Antibiotics
17%
Clostridium Difficile Infection
16%
Methicillin Resistant Staphylococcus Aureus
16%
Streptococcus Pneumoniae
16%
Carbapenem-Resistant Enterobacteriaceae
16%
Acinetobacter Baumannii
16%
Emergency Care
14%
Infection Prevention
12%
Long-Term Care
12%
Quinolone Derivative
12%
COVID-19
12%
Prevalence
12%
Cohort Effect
10%
Drug Therapy
10%
Antibiotic Therapy
10%
Bacteremia
9%
Fourier Transform Infrared Spectroscopy
9%
Healthcare Associated Infection
9%
Cross Sectional Study
8%
Oncology
8%
Burkholderia cenocepacia
8%
Case Fatality Rate
8%
Granulomatous Mastitis
8%
Respiratory Tract Infection
8%
Tracheostomy
8%
Peptoclostridium difficile
8%
Hand Hygiene
8%
Meticillin
8%
Staphylococcus Aureus
8%
Handwashing
8%
West Nile Fever
8%
Asymptomatic Bacteriuria
8%
Fulminant
8%
Hospital Cost
8%
Bacterium Culture
8%
Boric Acid
8%
Urinary System
8%
Single Drug Dose
8%
Ceftriaxone
8%
Disease
8%
Pathogen
7%
Nursing and Health Professions
Health Care Personnel
28%
Subacute Care
25%
Carbapenem Resistant Enterobacteriaceae
25%
Bloodstream Infection
25%
Carbapenem
25%
Infection Control
24%
Prevalence
20%
Intensive Care Unit
18%
Catheter Infection
18%
Infection
18%
Antiinfective Agent
17%
Cross-Sectional Study
16%
Methicillin-Resistant Staphylococcus Aureus
16%
Disease
16%
Clostridium Difficile Infection
16%
Emergency Care
14%
Infection Prevention
12%
Urinary Tract Infection
12%
Severe Acute Respiratory Syndrome
9%
Compliance
9%
Healthcare Associated Infection
9%
Ward
8%
Hand Washing
8%
Long Term Care
8%
Asymptomatic Bacteriuria
8%
Klebsiella Pneumoniae Infection
8%
Seroprevalence
8%
Prevention and Control
8%
Health Service
8%
Vaccination Policy
8%
Fourier Transform Infrared Spectroscopy
8%
Hospital Setting
8%
Meticillin
8%
Hospital Cost
8%
Boric Acid
8%
Bacterium Culture
8%
Urine Culture
7%
Rate Ratio
7%
Odds Ratio
6%
Urine Sampling
6%
Disease Control
5%
Prophylaxis
5%
Infection Rate
5%
